From waking to sleeping: neuronal and chemical substrates.
暂无分享,去创建一个
[1] R Szymusiak,et al. Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation. , 1995, Sleep.
[2] Mark C. Jones. PRINCIPLES AND PRACTICE OF SLEEP MEDICINE , 1990 .
[3] Barbara E. Jones,et al. Basic Mechanisms of Sleep-Wake States , 2005 .
[4] H. Haas,et al. The physiology of brain histamine , 2001, Progress in Neurobiology.
[5] S. A. Shefner,et al. GABAA and GABAB receptors and the ionic mechanisms mediating their effects on locus coeruleus neurons. , 1991, Progress in brain research.
[6] M. Mühlethaler,et al. Pharmacological characterization and differentiation of non‐cholinergic nucleus basalis neurons in vitro , 1998, Neuroreport.
[7] M. Lancel. Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. , 1999, Sleep.
[8] Jun Lu,et al. The &agr;2-Adrenoceptor Agonist Dexmedetomidine Converges on an Endogenous Sleep-promoting Pathway to Exert Its Sedative Effects , 2003, Anesthesiology.
[9] B. Jones,et al. c‐Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery , 2002, The European journal of neuroscience.
[10] R. Szymusiak,et al. Sleep-waking discharge of basal forebrain projection neurons in cats , 1989, Brain Research Bulletin.
[11] C. Gottesmann,et al. GABA mechanisms and sleep , 2002, Neuroscience.
[12] R. Broughton,et al. Effects of Nocturnal Gamma-Hydroxybutyrate on Sleep/Waking Patterns in Narcolepsy-Cataplexy , 1980, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[13] J. Fritschy,et al. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. , 2003, Pharmacology & therapeutics.
[14] Jerome M. Siegel,et al. Behavioral Correlates of Activity in Identified Hypocretin/Orexin Neurons , 2005, Neuron.
[15] B. Jones,et al. Differential c-Fos Expression in Cholinergic, Monoaminergic, and GABAergic Cell Groups of the Pontomesencephalic Tegmentum after Paradoxical Sleep Deprivation and Recovery , 1999, The Journal of Neuroscience.
[16] J. Rossier,et al. Identification of sleep-promoting neurons in vitro , 2000, Nature.
[17] M. Jouvet,et al. Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat , 1992, Brain Research.
[18] G Oakson,et al. Neuronal activities in brain-stem cholinergic nuclei related to tonic activation processes in thalamocortical systems , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[19] O. Hassani,et al. Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking Cycle , 2005, The Journal of Neuroscience.
[20] D. McCormick. Neurotransmitter actions in the thalamus and cerebral cortex and their role in neuromodulation of thalamocortical activity , 1992, Progress in Neurobiology.
[21] J. Gotman,et al. High-frequency γ electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat , 1997, Neuroscience.
[22] M. Modirrousta,et al. Gabaergic neurons with α2-adrenergic receptors in basal forebrain and preoptic area express c-Fos during sleep , 2004, Neuroscience.
[23] D. Paré,et al. Short-lasting nicotinic and long-lasting muscarinic depolarizing responses of thalamocortical neurons to stimulation of mesopontine cholinergic nuclei. , 1991, Journal of neurophysiology.
[24] B. Jones. Paradoxical REM sleep promoting and permitting neuronal networks. , 2004, Archives italiennes de biologie.
[25] A. Alonso,et al. Discharge Profiles of Juxtacellularly Labeled and Immunohistochemically Identified GABAergic Basal Forebrain Neurons Recorded in Association with the Electroencephalogram in Anesthetized Rats , 2000, The Journal of Neuroscience.
[26] A. Alonso,et al. Cholinergic Basal Forebrain Neurons Burst with Theta during Waking and Paradoxical Sleep , 2005, The Journal of Neuroscience.
[27] D. McCormick,et al. Cellular mechanisms of a synchronized oscillation in the thalamus. , 1993, Science.
[28] B. Antkowiak,et al. Molecular and neuronal substrates for general anaesthetics , 2004, Nature Reviews Neuroscience.
[29] A. Steiger,et al. The GABAA agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans , 1997, Psychopharmacology.
[30] I. Gritti,et al. GABAergic and other noncholinergic basal forebrain neurons, together with cholinergic neurons, project to the mesocortex and isocortex in the rat , 1997, The Journal of comparative neurology.
[31] M. Serafin,et al. Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices , 2005, Neuroscience.
[32] M. Mancia,et al. The Diencephalon and Sleep , 1990 .
[33] R. Szymusiak,et al. Activation of c‐fos in GABAergic neurones in the preoptic area during sleep and in response to sleep deprivation , 2004, The Journal of physiology.
[34] F. Fujiyama,et al. Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex , 2001, The Journal of comparative neurology.
[35] E. Mignot,et al. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders , 2002, Nature Neuroscience.
[36] S. Williams,et al. Gamma-hydroxybutyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB receptor-mediated hyperpolarization , 1995, Neuroscience.
[37] Jon T. Willie,et al. Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.
[38] E. Mignot,et al. PHARMACOLOGICAL ASPECTS OF HUMAN AND CANINE NARCOLEPSY , 1997, Progress in Neurobiology.
[39] R. Szymusiak,et al. Chapter 13 – Sleep-Promoting Mechanisms in Mammals , 2005 .
[40] Emmanuel Mignot,et al. The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.
[41] Dennis McGinty,et al. Sleep–waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats , 1998, Brain Research.
[42] G. Di Chiara,et al. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Alonso,et al. Sleep-wake related discharge properties of basal forebrain neurons recorded with micropipettes in head-fixed rats. , 2004, Journal of neurophysiology.
[44] A. Davies,et al. Intrinsic programmes of growth and survival in developing vertebrate neurons , 1994, Trends in Neurosciences.
[45] J. Gillin,et al. Rapid Eye Movement (REM) sleep: cholinergic mechanisms , 1984, Psychological Medicine.
[46] I. Gritti,et al. Projections of GABAergic and cholinergic basal forebrain and GABAergic preoptic‐anterior hypothalamic neurons to the posterior lateral hypothalamus of the rat , 1994, The Journal of comparative neurology.
[47] A. Alonso,et al. Rhythmically discharging basal forebrain units comprise cholinergic, GABAergic, and putative glutamatergic cells. , 2003, Journal of neurophysiology.
[48] Damien Gervasoni,et al. The rat ponto‐medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study , 2002, The European journal of neuroscience.
[49] B. Jones,et al. c-Fos Expression in GABAergic, Serotonergic, and Other Neurons of the Pontomedullary Reticular Formation and Raphe after Paradoxical Sleep Deprivation and Recovery , 2000, The Journal of Neuroscience.
[50] A. Cuello,et al. Afferents to the basal forebrain cholinergic cell area from pontomesencephalic—catecholamine, serotonin, and acetylcholine—neurons , 1989, Neuroscience.
[51] B. Jones,et al. Evidence for glutamate, in addition to acetylcholine and GABA, neurotransmitter synthesis in basal forebrain neurons projecting to the entorhinal cortex , 2001, Neuroscience.
[52] B. Jones. Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. , 2004, Progress in brain research.
[53] M. Modirrousta,et al. Alpha 2 adrenergic receptors on GABAergic, putative sleep‐promoting basal forebrain neurons , 2003, The European journal of neuroscience.
[54] R. McCarley,et al. Activation of Ventrolateral Preoptic Neurons During Sleep , 1996, Science.
[55] B. Jacobs,et al. Activity of brain serotonergic neurons in the behaving animal. , 1991, Pharmacological reviews.
[56] O. Hayaishi,et al. Firing of neurons in the preoptic/anterior hypothalamic areas in rat: its possible involvement in slow wave sleep and paradoxical sleep , 1994, Neuroscience Research.
[57] K. Sakai,et al. Unitary characteristics of presumptive cholinergic tegmental neurons during the sleep-waking cycle in freely moving cats , 2004, Experimental Brain Research.
[58] P. Luppi,et al. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. , 2004, Sleep.
[59] W. Schultz,et al. Preferential activation of midbrain dopamine neurons by appetitive rather than aversive stimuli , 1996, Nature.
[60] F. Bloom,et al. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle , 1981, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[61] Thomas E. Scammell,et al. The sleep switch: hypothalamic control of sleep and wakefulness , 2001, Trends in Neurosciences.
[62] W. Mendelson. Chapter 36 – Hypnotic Medications: Mechanisms of Action and Pharmacologic Effects , 2005 .
[63] J A Hobson,et al. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. , 1975, Science.
[64] Sebastiaan Overeem,et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains , 2000, Nature Medicine.
[65] T. Liljefors,et al. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic. , 2004, Biochemical pharmacology.